The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Morphine market was valued at US$ 15700 million in 2023 and is anticipated to reach US$ 26050 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
North American market for Morphine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Morphine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Morphine include Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Sanofi Winthrop Industrie, Macfarlan Smith, Sun Pharmaceutical Industries, Qinghai Pharmaceutical and Northeast Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Morphine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Morphine.
Report Scope
The Morphine market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Morphine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Morphine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Sanofi Winthrop Industrie
Macfarlan Smith
Sun Pharmaceutical Industries
Qinghai Pharmaceutical
Northeast Pharmaceutical Group
Segment by Type
Oral Tablets
Injection
Capsule
Others
Segment by Application
Anesthesia
Cough Suppressant
Diarrhea Suppressant
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Morphine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Morphine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Morphine market was valued at US$ 15700 million in 2023 and is anticipated to reach US$ 26050 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
North American market for Morphine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Morphine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Morphine include Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Sanofi Winthrop Industrie, Macfarlan Smith, Sun Pharmaceutical Industries, Qinghai Pharmaceutical and Northeast Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Morphine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Morphine.
Report Scope
The Morphine market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Morphine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Morphine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Sanofi Winthrop Industrie
Macfarlan Smith
Sun Pharmaceutical Industries
Qinghai Pharmaceutical
Northeast Pharmaceutical Group
Segment by Type
Oral Tablets
Injection
Capsule
Others
Segment by Application
Anesthesia
Cough Suppressant
Diarrhea Suppressant
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Morphine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Morphine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Morphine Market Overview
1.1 Product Overview and Scope of Morphine
1.2 Morphine Segment by Type
1.2.1 Global Morphine Market Value Comparison by Type (2024-2030)
1.2.2 Oral Tablets
1.2.3 Injection
1.2.4 Capsule
1.2.5 Others
1.3 Morphine Segment by Application
1.3.1 Global Morphine Market Value by Application: (2024-2030)
1.3.2 Anesthesia
1.3.3 Cough Suppressant
1.3.4 Diarrhea Suppressant
1.4 Global Morphine Market Size Estimates and Forecasts
1.4.1 Global Morphine Revenue 2019-2030
1.4.2 Global Morphine Sales 2019-2030
1.4.3 Global Morphine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Morphine Market Competition by Manufacturers
2.1 Global Morphine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Morphine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Morphine Average Price by Manufacturers (2019-2024)
2.4 Global Morphine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Morphine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Morphine, Product Type & Application
2.7 Morphine Market Competitive Situation and Trends
2.7.1 Morphine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Morphine Players Market Share by Revenue
2.7.3 Global Morphine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Morphine Retrospective Market Scenario by Region
3.1 Global Morphine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Morphine Global Morphine Sales by Region: 2019-2030
3.2.1 Global Morphine Sales by Region: 2019-2024
3.2.2 Global Morphine Sales by Region: 2025-2030
3.3 Global Morphine Global Morphine Revenue by Region: 2019-2030
3.3.1 Global Morphine Revenue by Region: 2019-2024
3.3.2 Global Morphine Revenue by Region: 2025-2030
3.4 North America Morphine Market Facts & Figures by Country
3.4.1 North America Morphine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Morphine Sales by Country (2019-2030)
3.4.3 North America Morphine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Morphine Market Facts & Figures by Country
3.5.1 Europe Morphine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Morphine Sales by Country (2019-2030)
3.5.3 Europe Morphine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Morphine Market Facts & Figures by Country
3.6.1 Asia Pacific Morphine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Morphine Sales by Country (2019-2030)
3.6.3 Asia Pacific Morphine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Morphine Market Facts & Figures by Country
3.7.1 Latin America Morphine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Morphine Sales by Country (2019-2030)
3.7.3 Latin America Morphine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Morphine Market Facts & Figures by Country
3.8.1 Middle East and Africa Morphine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Morphine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Morphine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Morphine Sales by Type (2019-2030)
4.1.1 Global Morphine Sales by Type (2019-2024)
4.1.2 Global Morphine Sales by Type (2025-2030)
4.1.3 Global Morphine Sales Market Share by Type (2019-2030)
4.2 Global Morphine Revenue by Type (2019-2030)
4.2.1 Global Morphine Revenue by Type (2019-2024)
4.2.2 Global Morphine Revenue by Type (2025-2030)
4.2.3 Global Morphine Revenue Market Share by Type (2019-2030)
4.3 Global Morphine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Morphine Sales by Application (2019-2030)
5.1.1 Global Morphine Sales by Application (2019-2024)
5.1.2 Global Morphine Sales by Application (2025-2030)
5.1.3 Global Morphine Sales Market Share by Application (2019-2030)
5.2 Global Morphine Revenue by Application (2019-2030)
5.2.1 Global Morphine Revenue by Application (2019-2024)
5.2.2 Global Morphine Revenue by Application (2025-2030)
5.2.3 Global Morphine Revenue Market Share by Application (2019-2030)
5.3 Global Morphine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Corporation Information
6.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Morphine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mallinckrodt Pharmaceuticals Morphine Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.2 Alcaliber
6.2.1 Alcaliber Corporation Information
6.2.2 Alcaliber Description and Business Overview
6.2.3 Alcaliber Morphine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alcaliber Morphine Product Portfolio
6.2.5 Alcaliber Recent Developments/Updates
6.3 Purdue Pharma
6.3.1 Purdue Pharma Corporation Information
6.3.2 Purdue Pharma Description and Business Overview
6.3.3 Purdue Pharma Morphine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Purdue Pharma Morphine Product Portfolio
6.3.5 Purdue Pharma Recent Developments/Updates
6.4 Sanofi Winthrop Industrie
6.4.1 Sanofi Winthrop Industrie Corporation Information
6.4.2 Sanofi Winthrop Industrie Description and Business Overview
6.4.3 Sanofi Winthrop Industrie Morphine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Winthrop Industrie Morphine Product Portfolio
6.4.5 Sanofi Winthrop Industrie Recent Developments/Updates
6.5 Macfarlan Smith
6.5.1 Macfarlan Smith Corporation Information
6.5.2 Macfarlan Smith Description and Business Overview
6.5.3 Macfarlan Smith Morphine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Macfarlan Smith Morphine Product Portfolio
6.5.5 Macfarlan Smith Recent Developments/Updates
6.6 Sun Pharmaceutical Industries
6.6.1 Sun Pharmaceutical Industries Corporation Information
6.6.2 Sun Pharmaceutical Industries Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Morphine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Industries Morphine Product Portfolio
6.6.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.7 Qinghai Pharmaceutical
6.6.1 Qinghai Pharmaceutical Corporation Information
6.6.2 Qinghai Pharmaceutical Description and Business Overview
6.6.3 Qinghai Pharmaceutical Morphine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qinghai Pharmaceutical Morphine Product Portfolio
6.7.5 Qinghai Pharmaceutical Recent Developments/Updates
6.8 Northeast Pharmaceutical Group
6.8.1 Northeast Pharmaceutical Group Corporation Information
6.8.2 Northeast Pharmaceutical Group Description and Business Overview
6.8.3 Northeast Pharmaceutical Group Morphine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Northeast Pharmaceutical Group Morphine Product Portfolio
6.8.5 Northeast Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Morphine Industry Chain Analysis
7.2 Morphine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Morphine Production Mode & Process
7.4 Morphine Sales and Marketing
7.4.1 Morphine Sales Channels
7.4.2 Morphine Distributors
7.5 Morphine Customers
8 Morphine Market Dynamics
8.1 Morphine Industry Trends
8.2 Morphine Market Drivers
8.3 Morphine Market Challenges
8.4 Morphine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
